FOREST LABS, SPAIN'S ALMIRALL IN DRUG DEVELOPMENT PACT

A A

Forest Laboratories Inc. and closely held, Barcelona-based pharmaceutical company Almirall agreed to develop, market and distribute the Spanish company's chronic obstructive pulmonary disease treatment, LAS34273, in the U.S.

Therapeutics Daily (http://www.therapeuticsdaily.com/news/article.cfm?contentValue=849628&contentType=sentryarticle&channelID=29)